RAP 0.00% 20.5¢ resapp health limited

Australia-China Biotech Invest 2017, page-5

  1. 2,702 Posts.
    lightbulb Created with Sketch. 504
    A lot of truth there @ClownTrader...

    The full scope of this product will only be realised after the FDA approvals have finished for ALL illnesses, then uploaded to the Telehealth world which hasn't really been discussed yet.
    I'm hoping the trial process that's currently taking place is also testing every age group so the "rolling" FDA process will be as seamless as possible.
    Any thoughts @Red bar @LJsilver @Portsmouth @rockboy etc etc.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.